Sequoia Sciences, Inc.
St. Louis, MO, US· latest recorded location
Sequoia Sciences, Inc. is named on 15 US grants and 18 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 15
- Published applications
- 18
- Inventors
- 18
- Granted in 2026 so far
- 0
- Most recent grant
- 27 Nov 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 1 | 2 |
| 2009 | 2 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 3 | 5 |
| 2016 | 4 | 3 |
| 2017 | 1 | 2 |
| 2018 | 3 | 2 |
| 2019 | 0 | 1 |
By publication year.
Technology areas
Share of 33 documents
- A61KMedicines and medical preparations29
- Y02ATechnologies for adaptation to climate change23
- C07DHeterocyclic compounds4
- C07JSteroids4
- A61PTherapeutic uses of medicines3
- A61QSpecific use of cosmetics or similar toiletry preparations2
- B01JChemical or physical processes2
- C07CAcyclic or carbocyclic compounds2
- C12NMicroorganisms or enzymes2
- C40BCombinatorial chemistry2
Recent patents
- Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections27 Nov 2018US 10,137,192 B2
- Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections28 Aug 2018US 10,058,608 B2
- Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections30 Jan 2018US 9,878,037 B2
- Phenethyldihydrobenzodioxolones and methods of use7 Feb 2017US 9,562,031 B1
- Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections29 Nov 2016US 9,504,743 B2
- Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections31 Jan 2019US 2019/0030159 A1
- Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections16 Aug 2018US 2018/0228891 A1
- Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections1 Feb 2018US 2018/0028648 A1
- Bifidenone Compositions and Methods of Use16 Mar 2017US 2017/0073324 A1
- Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections2 Feb 2017US 2017/0028060 A1
Most cited
By later US patents
- Compounds, compositions and methods for controlling biofilms and bacterial infections25US 7,612,045 B22009
- Inhibition of biofilm formation17US 7,604,978 B22009
- Inhibitors of bacterial biofilms and related methods15US 8,324,264 B12012
- Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections11US 9,149,522 B22015
- Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections8US 9,017,698 B22015